The Discounted Cash Flow (DCF) valuation of Editas Medicine Inc (EDIT) is (65.24) USD. With the latest stock price at 2.18 USD, the upside of Editas Medicine Inc based on DCF is -3092.5%.
Based on the latest price of 2.18 USD and our DCF valuation, Editas Medicine Inc (EDIT) is a sell. selling EDIT stocks now will result in a potential gain of 3092.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.2% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (231.63) - (38.91) | (65.24) |
| Upside | -10725.0% - -1885.0% | -3092.5% |